Composition and method containing optically pure (s) metoprolol

Details Composition and method containing optically pure (s) metoprolol Composition and method containing optically pure (s) metoprolol

A - Human Necessities

61

K

A61K 31/135 (2006.01)

Patent

CA 2106494

2106494 9216197 PCTABS00016 Optically pure (S) metoprolol, which is substantially free of the (R) enantiomer, is a potent beta-blocker for treating myocardial infarction and for relieving the symptoms of angina pectoris, cardiac arrhythmia and hypertension in individuals. A method is disclosed utilizing the optically pure (S) configurational enantiomer of metoprolol for treating cardiovascular disorders while reducing undesirable side effects associated with the administration of beta-blockers.

Affiliated with

Also associated with

Rating

Composition and method containing optically pure (s) metoprolol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method containing optically pure (s) metoprolol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method containing optically pure (s) metoprolol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1390601